{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obstetrical and Gynecological Survey - Vol. 80, No. 2

Activity Steps

2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

CME Article 3: Management of Maternal Genetic Conditions in Pregnancy, Part 1: Disorders of the Connective Tissue, Muscle, Vascular, and Skeletal Systems -- Describe how to manage patients with genetic disorders that place them at high risk for aortic dissection, uterine rupture and cerebral hemorrhage during pregnancy; formulate delivery plans for patients with skeletal dysplasias; interpret ultrasound findings in the context of parental genetic disorders; explain how to counsel patients with genetic disorders regarding inheritance pattern and options for preimplantation and prenatal testing.
CME Article 4: Ovarian Stem Cells: Will the Dream of Neo-Folliculogenesis After Birth Become Real? -- Describe the main characteristics of stem cells and the sources from which they can be isolated; discuss the presence of ovarian stem cells (OSCs) in the ovary of adult women and how they can support the process of neo-folliculogenesis; explain how ovarian stem cells (OSCs) may be used as a possible therapeutic strategy for cancer patients or patients at risk of premature ovarian insufficiency.
CME Article 5: The Clinical Utility of Measures of Ovarian Reserve -- Define ovarian reserve; describe the available measures of ovarian reserve; discuss the clinical utility of measures of ovarian reserve.

Disclosures

All authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $30.00

Credits:

ACCME 3.0 CME

Accreditation Statement

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner

Professions: Physician

Test Code: OGS0225

Published: February 2025

Expires: 1/31/2027

Sources: Obstetrical & Gynecological Survey

Required Passing Score: 9/12 (75%)

Authors: Anne Mardy, MD and Madeline Whitney, MD; Stefano Canosa, MSc, PhD, Erica Silvestris, MD, PhD, Andrea Roberto Carosso, MD, Alessandro Ruffa, MD, Bernadette Evangelisti,MD, Gianluca Gennarelli, MD, PhD, Gennaro Cormio, MD, PhD, Vera Loizzi, MD, PhD, Alessandro Rolfo, MSc, PhD, Chiara Benedetto, MD, PhD, and Alberto Revelli, MD, PhDk; Katherine M. Baker, MD, Rodolfo FernandezCriado, MD, Jennifer L. Eaton, MD, and Virginia A. Mensah, MD

Categories: Gynecological , Obstetrical

Specialties: Gynecology, OB/GYN

Topics: Maternal Genetic Conditions , Ovarian Reserve , Ovarian Stem Cells